Hendrik Scholl is Professor and Chairman of the Department of Ophthalmology, University of Basel, Switzerland. He is also one of the two founding directors of the Institute of Molecular and Clinical Ophthalmology Basel (IOB). He specializes in the treatment of reti-nal diseases, specifically inherited retinal and macular dystrophies, and in research on retinal neurodegeneration.
Prof. Scholl is a graduate of the Medical Faculty of the University of Tübingen/Germany and holds a Master of Arts from Tübingen’s Faculty of Philosophy. He completed a residency at Tübingen’s University Eye Hospital prior to a fellowship at Moorfields Eye Hospi-tal & Institute of Ophthalmology in London/UK and a DFG Heisen-berg fellowship on macular disorders. After having held several ac-ademic positions at the Medical Faculty of the University of Bonn/Germany, he was appointed as Professor of Ophthalmology in 2010 and subsequently as Endowed Chair at the Wilmer Eye Institute of John Hopkins University Medical School in Baltimore, USA.
In 2016, Prof. Scholl joined the University Basel as Professor and Chairman of the Department of Ophthalmology. Prof. Scholl has authored over 250 articles and reviews in peer-reviewed journals and received numerous prestigious awards. In 2023, he received an honorary doctorate of Semmelweis University Budapest.
